G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15.07	32.22	94.59	221.19	207.31	269.21
Short-Term Investments	45.66	49.94	50.48	-	-	-
Cash & Short-Term Investments	60.73	82.16	145.07	221.19	207.31	269.21
Cash Growth	-41.74%	-43.37%	-34.41%	6.70%	-22.99%	-27.10%
Receivables	13.31	12.69	11.09	5.69	0.24	-
Inventory	13.38	12.44	16.18	3.47	-	-
Prepaid Expenses	5.44	7.6	7.09	13.16	8.79	1.73
Restricted Cash	0.06	0.06	0.06	0.06	0.06	0.06
Total Current Assets	92.92	114.95	179.5	243.57	216.39	271
Property, Plant & Equipment	5.58	6.38	7.95	9.05	10.51	13.39
Other Long-Term Assets	0.19	0.21	0.51	1.48	1.65	0.44
Total Assets	98.69	121.54	187.97	254.09	228.55	284.83
Accounts Payable	5.16	3.99	7.43	2.9	3.57	3.68
Accrued Expenses	17.08	21.89	25.56	23.18	16.49	15.4
Current Portion of Leases	-	1.28	-	-	-	0.68
Current Unearned Revenue	0.95	0.62	0.01	0.03	0.24	-
Other Current Liabilities	2.91	1.94	2.59	1.51	3.15	-
Total Current Liabilities	37.5	29.72	35.59	27.61	23.44	19.77
Long-Term Debt	32.91	51.56	77.02	75.19	19.89	-
Long-Term Leases	3.65	4.34	5.62	6.75	7.87	9.54
Long-Term Unearned Revenue	-	0.5	1	1	-	-
Other Long-Term Liabilities	0.04	0.04	-	-	-	-
Total Liabilities	74.1	86.15	119.22	110.55	51.2	29.3
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	820.27	815.37	800.77	728	613.46	592.38
Retained Earnings	-795.67	-779.99	-732.02	-584.46	-436.11	-336.85
Treasury Stock	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Total Common Equity	24.59	35.39	68.75	143.54	177.35	255.53
Shareholders' Equity	24.59	35.39	68.75	143.54	177.35	255.53
Total Liabilities & Equity	98.69	121.54	187.97	254.09	228.55	284.83
Total Debt	47.96	57.17	82.63	81.94	27.76	10.22
Net Cash (Debt)	12.77	24.98	62.44	139.25	179.55	258.99
Net Cash Growth	-73.57%	-59.99%	-55.16%	-22.45%	-30.67%	-29.87%
Net Cash Per Share	0.25	0.48	1.43	3.32	4.74	6.91
Filing Date Shares Outstanding	52.76	52.2	51.66	42.71	41.96	37.64
Total Common Shares Outstanding	52.7	51.93	51.5	42.56	38.11	37.61
Working Capital	55.42	85.23	143.91	215.95	192.95	251.23
Book Value Per Share	0.47	0.68	1.33	3.37	4.65	6.79
Tangible Book Value	24.59	35.39	68.75	143.54	177.35	255.53
Tangible Book Value Per Share	0.47	0.68	1.33	3.37	4.65	6.79
Machinery	2.03	2.03	2.03	1.53	1.53	2.27
Leasehold Improvements	1.78	1.78	1.78	1.78	1.78	1.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q